Aortic Stent Grafts Market is expected to reach US$ 5,103.48 Million by 2034

Abdominal Aortic Stent Grafts Segment Leading the Aortic Stent Grafts Market by Product Type

According to our new research study on “Aortic Stent Grafts Market Forecast to 2034 – Global Analysis – by product type, end user,” the Aortic Stent Grafts Market size is expected to grow from US$ 2,763.37 million in 2025 to US$ 5,103.48 million by 2034, with a CAGR of 7.1% during 2025–2034. Development in the Aortic Stent Grafts Market is taking place through increasing use of minimally invasive methods in treating abdominal and thoracic aortic disease cases. This market development is enabled through innovations in graft design, anchoring, deployment, and conformability, which have helped make endovascular repair possible in increasingly challenging anatomical scenarios. This market is gradually making a transition from traditional endografts to fenestrated, branched, and anatomically flexible stent grafts that are meant for addressing difficult aneurysms, dissections, challenging landing zones, and branch vessels. Moreover, innovations in CT based anatomy planning and 3-D imaging are helping in providing better sizing and planning for devices. The focus on longevity of graft, sealing capacity, and prevention of endoleaks and migrations is also affecting product innovation. Additionally, increased applications in complex and emergency aortic repairs are helping increase the applicability of the technology.

The disease burden posed by aortic aneurysms is large and consistent, involving progressive degeneration of aortic wall leading to enlargement of the vessel and a high risk of fatal rupture or dissection. The disease burden is especially relevant among older patient cohorts, because the following risk factors have been identified for the development of aortic aneurysm: older age, male gender, history of smoking, hypertension, atherosclerosis, and genetics. The burden of the disease is accentuated by its typically asymptomatic progression, during which the aneurysms remain unrecognized until they reach a size that poses an increased risk of rupture.

The disease burden justifies the market potential for endovascular therapy devices for the cases of significant aneurysm growth or onset of symptoms. Endovascular aneurysm repair (EVAR) with abdominal aortic stent grafts and thoracic endovascular aortic repair (TEVAR) with thoracic stent grafts offer minimally invasive alternatives to surgery for patients with anatomically appropriate aneurysms. There is epidemiological evidence supporting the underlying demand potential. As per the Global Burden of Disease Study 2021, the world saw 153,927 deaths caused by aortic aneurysms in 2021; compared with 1990, the number of deaths grew significantly, but the age-standardized mortality rate decreased. 

Consequently, the ongoing global disease burden of aortic aneurysms ensures the target patient population that can be served by abdominal and thoracic endovascular repair procedures. This ensures ongoing development by manufacturers of improved aortic graft performance, adaptability, delivery technology, and endovascular systems; on the other hand, healthcare professionals need to develop more capabilities in disease diagnosis and procedural expertise. With the increasing avenues for disease identification and management, the ongoing burden of aortic aneurysms will therefore continue to drive the global aortic stent graft market.

The scope of the Aortic Stent Grafts Market report includes an assessment of the market performance in North America, Europe, Asia Pacific, Middle East & Africa and South and Central America. In terms of revenue, North America dominated the Aortic Stent Grafts Market share in 2025. 

The conventional abdominal and thoracic stent grafts are based on the defined range of anatomical sizes, but significant variations in the aortic diameter, angulations, landing zones, branch vessel orientations, and extension of the disease process may render the standard devices unsuitable. In order to take into account the aforementioned anatomical variations, patient-specific systems rely on personalized fenestrations, branches, scallops, and dimensions of the grafts that have been planned preoperatively using the precise imaging. 

This paradigm shift comes in the wake of advances in the computational tomography planning, device manufacturing, and clinical experience with aortic reconstruction procedures. This evolution of the technology is increasingly becoming an important factor affecting the market for aortic stent grafts by altering the approaches used in the design and evaluation of the advanced endovascular devices. The patient-specific fenestrated and branched stent grafts are especially valuable in the aneurysms extending to renal, visceral, or supra-aortic vessels.

One such instance was described by Cook Medical in 2025 when the company stated that patient enrollment had been completed in the worldwide clinical trial of its ZENITH FENESTRATED+ Endovascular Graft, which is an FDA-approved IDE study for the evaluation of the device system for aneurysms that involve major visceral arteries, thus highlighting industry players' efforts towards developing new devices based on patients’ complex anatomy.

This shift in approach towards device design is transforming the aortic stent graft market in terms of its product development and clinical application. Companies are now offering differentiated platforms by using their anatomical specificity, branch preservation feature and imaging planning tools, while specialized centers are adopting individualized device selection for complicated EVAR and TEVAR procedures.

Medtronic plc, W. L. Gore & Associates, Inc., Cook Medical LLC, Terumo Aortic, Endologix LLC, Artivion, Inc., MicroPort Endovascular MedTech Co., Ltd., LifeTech Scientific Corporation, Lombard Medical Technologies and Braile Biomédica S.A. are among the leading companies profiled in the Aortic Stent Grafts Market report. 

By product, the market is segmented into abdominal aortic stent grafts and thoracic aortic stent grafts. Based on end user, the market is segmented into hospitals and ambulatory surgical centers. By geography, the market is divided into North America (the US, Canada and Mexico), Europe (Germany, United Kingdom, France, Italy, Spain and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA) and South & Central America (Brazil, Argentina and Rest of SCAM).